Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.

about

Atypical small acinar proliferation at index prostate biopsy: rethinking the re-biopsy paradigm.

Item

http://www.wikidata.org/entity/Q48139219

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@en

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@nl

type

Item

label

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@en

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@nl

prefLabel

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@en

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@nl

P1476

Atypical small acinar prolifer ...... inking the re-biopsy paradigm.

@en

P2093

Ali M Mahmoud

http://www.w3.org/2001/XMLSchema#string

Christopher D Kosarek

http://www.w3.org/2001/XMLSchema#string

Eduardo J Eyzaguirre

http://www.w3.org/2001/XMLSchema#string

Eduardo Orihuela

http://www.w3.org/2001/XMLSchema#string

Joseph N Sonstein

http://www.w3.org/2001/XMLSchema#string

Leslie A Ynalvez

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes of localized prostate cancer following conservative management

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.

Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.

Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies

Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy").

Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-017-1714-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Preston Kerr

Stephen B Williams

P577

2017-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29064003

http://www.w3.org/2001/XMLSchema#string

P921

biopsy

P932

5760352

http://www.w3.org/2001/XMLSchema#string